Theravance Biopharma, Inc. Annual Earnings Per Share, Basic in USD/shares from 2019 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Theravance Biopharma, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2019 to 2023.
  • Theravance Biopharma, Inc. Earnings Per Share, Basic for the quarter ending June 30, 2024 was -0.34 USD/shares, a 21.4% decline year-over-year.
  • Theravance Biopharma, Inc. Earnings Per Share, Basic for the twelve months ending June 30, 2024 was -0.92 USD/shares, a 108% decline year-over-year.
  • Theravance Biopharma, Inc. annual Earnings Per Share, Basic for 2023 was -1 USD/shares, a 108% decline from 2022.
  • Theravance Biopharma, Inc. annual Earnings Per Share, Basic for 2022 was 11.9 USD/shares.
  • Theravance Biopharma, Inc. annual Earnings Per Share, Basic for 2021 was -2.87 USD/shares, a 35.7% increase from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$1 -$13 -108% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-01
2022 $11.90 +$14.70 Jan 1, 2022 Dec 31, 2022 10-K 2024-03-01
2021 -$3 +$1.59 +35.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-01
2020 -$4 $0 -4.94% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 -$4 Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.